The Central Nervous System (CNS) therapeutics market is poised for significant growth as the global burden of neurological and psychiatric conditions continues to escalate. With increasing cases of Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, depression, anxiety, and schizophrenia, there is a surging demand for effective treatment...